- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Brandon Newman Discusses Payer, Academic Medical Center Collaboration
Brandon Newman, PharmD, MMHC, CSP, program director, specialty pharmacy, Vanderbilt University Medical Center, explains the benefits of collaboration between payers and academic centers and how this collaboration, in turn, benefits patients.
Brandon Newman, PharmD, MMHC, CSP, program director, specialty pharmacy, Vanderbilt University Medical Center, explains the benefits of collaboration between payers and academic centers and how this collaboration, in turn, benefits patients.
Transcript
What are the benefits of collaboration between payers and academic medical centers?
I think 1 thing, from my perspective in working for a dispensing pharmacy that’s based out of an academic medical center, is that first and foremost, we have to be able to dispense these drugs to these patients so we can follow the patients really closely. So, 1 big challenge with us is payer lockout. I think that if we can collaborate with a payer to be able to become part of that network to be able to fill for those patients, we can follow them closely, and, by following them closely, we can monitor their long-term clinical outcomes. I think that’s really where we can work closely with payers to make sure that patients are responding appropriately to these high-cost meds.
What are different examples of opportunities payers and academic centers can collaborate on?
I think 1 example of a way payers and manufacturers can collaborate is by a payer allowing a health system specialty pharmacy into their network and then by giving thresholds for the specialty pharmacy to be able to meet. Really, what that does is it holds the bar high so that patients are getting really good quality care, and then by providing this data back to the payer, they can use it for their analytics and benchmarking and be able to determine that patients are getting the best benefits and that the specialty pharmacy is doing a great job.
How does this collaboration, in turn, benefit patients?
What we found from patients that use our specialty pharmacy is that the satisfaction surveys are really good. We follow these patients really closely, make sure they’re doing well and not having any side effects, and managing those medications. The patients are really happy about that. We’re able to provide very personalized service. The patients meet the pharmacist face to face in clinic, they get phone calls as a follow-up from the pharmacist, and they’re very happy with it. We have very good satisfaction surveys that go to show that patients are happy with our service.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
